Soyeon Kim

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 6

Top Topics

Clinical Evaluation

Top Venues

Ophthalmology and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Minji Tak, Hawon Jeong, Jihoon Yun, Jihyun Kim, Soyeon Kim, Yoonsook Lee, Su Jin Park
In-Use Stability of SB12 (Eculizumab, Soliris Biosimilar) Diluted in Saline and Dextrose Infusion Solution after an Extended Storage Period. Drugs in R&D (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy (2023)
Peter K Kaiser, Jihoon Yun, Soyeon Kim, Jihyun Kim, Su Jin Park
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration. Ophthalmology and therapy 12 (2) (2023)